362 related articles for article (PubMed ID: 17710964)
1. Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women.
Chandeying V; Lamlertkittikul S
J Med Assoc Thai; 2007 Jul; 90(7):1274-80. PubMed ID: 17710964
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2004 Jan; 87(1):33-40. PubMed ID: 14971532
[TBL] [Abstract][Full Text] [Related]
3. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms.
Virojchaiwong P; Suvithayasiri V; Itharat A
Arch Gynecol Obstet; 2011 Aug; 284(2):411-9. PubMed ID: 20872225
[TBL] [Abstract][Full Text] [Related]
5. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
Manonai J; Chittacharoen A; Udomsubpayakul U; Theppisai H; Theppisai U
Menopause; 2008; 15(3):530-5. PubMed ID: 18202589
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham for menopausal women: A systematic review of clinical trials and the way forward.
Kongkaew C; Scholfield NC; Dhippayom T; Dilokthornsakul P; Saokaew S; Chaiyakunapruk N
J Ethnopharmacol; 2018 Apr; 216():162-174. PubMed ID: 29409850
[TBL] [Abstract][Full Text] [Related]
8. Isoflavone treatment for acute menopausal symptoms.
Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
[TBL] [Abstract][Full Text] [Related]
9. Effect of Pueraria mirifica on vaginal health.
Manonai J; Chittacharoen A; Theppisai U; Theppisai H
Menopause; 2007; 14(5):919-24. PubMed ID: 17415017
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
[TBL] [Abstract][Full Text] [Related]
11. Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats.
Urasopon N; Hamada Y; Asaoka K; Cherdshewasart W; Malaivijitnond S
Maturitas; 2007 Mar; 56(3):322-31. PubMed ID: 17101247
[TBL] [Abstract][Full Text] [Related]
12. Medical applications of phytoestrogens from the Thai herb Pueraria mirifica.
Malaivijitnond S
Front Med; 2012 Mar; 6(1):8-21. PubMed ID: 22460444
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety and acceptability of a seven-day, transdermal estradiol patch for estrogen replacement therapy.
Jarupanich T; Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2003 Sep; 86(9):836-45. PubMed ID: 14649968
[TBL] [Abstract][Full Text] [Related]
14. Review of alternative therapies for treatment of menopausal symptoms.
Amato P; Marcus DM
Climacteric; 2003 Dec; 6(4):278-84. PubMed ID: 15006249
[TBL] [Abstract][Full Text] [Related]
15. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders.
Russo R; Corosu R
Acta Biomed; 2003 Dec; 74(3):137-43. PubMed ID: 15055018
[TBL] [Abstract][Full Text] [Related]
16. Integrating phytoestrogens with prescription medicines--a conservative clinical approach to vasomotor symptom management.
Panay N
Maturitas; 2007 May; 57(1):90-4. PubMed ID: 17383125
[TBL] [Abstract][Full Text] [Related]
17. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial.
Albert A; Altabre C; Baró F; Buendía E; Cabero A; Cancelo MJ; Castelo-Branco C; Chantre P; Duran M; Haya J; Imbert P; Julía D; Lanchares JL; Llaneza P; Manubens M; Miñano A; Quereda F; Ribes C; Vázquez F
Phytomedicine; 2002 Mar; 9(2):85-92. PubMed ID: 11995954
[TBL] [Abstract][Full Text] [Related]
19. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica.
Lee YS; Park JS; Cho SD; Son JK; Cherdshewasart W; Kang KS
J Vet Sci; 2002 Dec; 3(4):273-7. PubMed ID: 12819377
[TBL] [Abstract][Full Text] [Related]
20. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
